How It Works
LL-37 is a small peptide the body naturally produces as part of its first line of immune defense, released by skin, gut, and immune cells when a threat is sensed. It is studied for its ability to disrupt the membranes of bacteria, fungi, and some viruses, acting almost like a built-in antimicrobial. Beyond directly targeting microbes, it appears to help coordinate the broader immune response, calling in immune cells and influencing how inflammation resolves. Because it works at the barrier surfaces where the body meets the outside world, it is explored in the context of skin, gut, and mucosal immune balance. Whether and how it fits into your plan is decided one-on-one with Dr. Rob.
The Science & Mechanism
LL-37 is the active 37-amino-acid peptide cleaved from the C-terminal end of hCAP18, the single cathelicidin protein encoded by the human CAMP gene; its name reflects the two leucine residues at its start. As a cationic, amphipathic alpha-helical peptide, it is studied for a direct antimicrobial mechanism in which its positive charge draws it to the negatively charged membranes of bacteria, fungi, and enveloped viruses, where it inserts and disrupts membrane integrity. Beyond this, research describes LL-37 as an immunomodulatory host-defense peptide that signals through the formyl peptide receptor-like 1 (FPRL1/FPR2) and can transactivate the epidermal growth factor receptor (EGFR). Through these pathways it is associated with chemotaxis of neutrophils, monocytes, and T cells, promotion of angiogenesis and wound re-epithelialization, and neutralization of bacterial lipopolysaccharide (LPS) to temper excessive endotoxin-driven inflammation. It is also studied for context-dependent effects on inflammatory signaling and for supporting epithelial barrier function at the skin and gut. Its expression is influenced by vitamin D signaling, which research explores as a link between vitamin D status and innate immunity.
Potential Benefits
- May support the body's innate antimicrobial defenses at barrier surfaces
- Studied for its role in host defense against bacteria, fungi, and some enveloped viruses
- May help support a balanced immune and inflammatory response
- Studied for its role in wound healing and skin barrier recovery
- May support gut lining integrity and mucosal immune balance
- Researched for neutralizing bacterial endotoxin (LPS) signaling
Who It May Be Best Suited For
- Individuals focused on supporting innate immune resilience
- Those exploring gut and mucosal barrier support
- People interested in skin barrier and recovery-focused protocols
- Clients building a physician-guided immune optimization plan
Important Considerations
LL-37 is offered as educational, research-informed content and any use is decided one-on-one with Dr. Rob based on your labs, health history, and goals. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease, and individual results vary. Dr. Rob reviews your candidacy, formulation, and protocol during your consultation to help it fit appropriately into your overall plan.
